Tyrosine kinase inhibitors in osteosarcoma: Adapting treatment strategiesa

Osteosarcoma (OS) is an aggressive primary bone malignancy that metastasizes rapidly. The standard of care has changed little over the previous four decades, and survival rates have plateaued. In this context, tyrosine kinase inhibitors (TKIs) emerge as potential treatments. A literature search was...

Descripción completa

Detalles Bibliográficos
Autores principales: Assi, Ahmad, Farhat, Mohamad, Hachem, Maria Catherine Rita, Zalaquett, Ziad, Aoun, Marven, Daher, Mohammad, Sebaaly, Amer, Kourie, Hampig-Raphaël
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10696463/
http://dx.doi.org/10.1016/j.jbo.2023.100511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10696463/
http://dx.doi.org/10.1016/j.jbo.2023.100511

Ejemplares similares